🚀 VC round data is live in beta, check it out!
Cofoe Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cofoe Medical and similar public comparables like MicroPort, Weigao Group, SonoScape, AdaptHealth and more.
Cofoe Medical Overview
About Cofoe Medical
Cofoe Medical Technology Co Ltd is engaged in the research and development, production, sales and service of home medical equipment.
Founded
2009
HQ
Employees
N/A
Website
Financials (LTM)
EV
$2B
Cofoe Medical Financials
Cofoe Medical reported last 12-month revenue of $527M and EBITDA of $89M.
In the same LTM period, Cofoe Medical generated $281M in gross profit, $89M in EBITDA, and $58M in net income.
Revenue (LTM)
Cofoe Medical P&L
In the most recent fiscal year, Cofoe Medical reported revenue of $497M and EBITDA of $92M.
Cofoe Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $527M | XXX | $497M | XXX | XXX | XXX |
| Gross Profit | $281M | XXX | $264M | XXX | XXX | XXX |
| Gross Margin | 53% | XXX | 53% | XXX | XXX | XXX |
| EBITDA | $89M | XXX | $92M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 18% | XXX | XXX | XXX |
| EBIT Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| Net Profit | $58M | XXX | $54M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 11% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cofoe Medical Stock Performance
Cofoe Medical has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Cofoe Medical's stock price is $8.43.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.0% | XXX | XXX | XXX | $0.26 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCofoe Medical Valuation Multiples
Cofoe Medical trades at 2.9x EV/Revenue multiple, and 17.0x EV/EBITDA.
EV / Revenue (LTM)
Cofoe Medical Financial Valuation Multiples
As of April 20, 2026, Cofoe Medical has market cap of $2B and EV of $2B.
Equity research analysts estimate Cofoe Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cofoe Medical has a P/E ratio of 30.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 2.9x | XXX | 3.1x | XXX | XXX | XXX |
| EV/EBITDA | 17.0x | XXX | 16.6x | XXX | XXX | XXX |
| EV/EBIT | 22.7x | XXX | 24.4x | XXX | XXX | XXX |
| EV/Gross Profit | 5.4x | XXX | 5.8x | XXX | XXX | XXX |
| P/E | 30.3x | XXX | 32.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 20.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cofoe Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cofoe Medical Margins & Growth Rates
Cofoe Medical's revenue in the last 12 month grew by 24%.
Cofoe Medical's rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cofoe Medical's rule of X is 73% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Cofoe Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 22% | XXX | 15% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 40% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 73% | XXX | XXX | XXX |
| S&M Expenses to Revenue | 34% | XXX | 34% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 5% | XXX | 5% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 41% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cofoe Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Cofoe Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| MicroPort | XXX | XXX | XXX | XXX | XXX | XXX |
| Weigao Group | XXX | XXX | XXX | XXX | XXX | XXX |
| SonoScape | XXX | XXX | XXX | XXX | XXX | XXX |
| AdaptHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Fukuda Denshi | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cofoe Medical M&A Activity
Cofoe Medical acquired XXX companies to date.
Last acquisition by Cofoe Medical was on XXXXXXXX, XXXXX. Cofoe Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cofoe Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCofoe Medical Investment Activity
Cofoe Medical invested in XXX companies to date.
Cofoe Medical made its latest investment on XXXXXXXX, XXXXX. Cofoe Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cofoe Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cofoe Medical
| When was Cofoe Medical founded? | Cofoe Medical was founded in 2009. |
| Where is Cofoe Medical headquartered? | Cofoe Medical is headquartered in China. |
| Is Cofoe Medical publicly listed? | Yes, Cofoe Medical is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Cofoe Medical? | Cofoe Medical trades under 301087 ticker. |
| When did Cofoe Medical go public? | Cofoe Medical went public in 2021. |
| Who are competitors of Cofoe Medical? | Cofoe Medical main competitors are MicroPort, Weigao Group, SonoScape, AdaptHealth. |
| What is the current market cap of Cofoe Medical? | Cofoe Medical's current market cap is $2B. |
| What is the current revenue of Cofoe Medical? | Cofoe Medical's last 12 months revenue is $527M. |
| What is the current revenue growth of Cofoe Medical? | Cofoe Medical revenue growth (NTM/LTM) is 24%. |
| What is the current EV/Revenue multiple of Cofoe Medical? | Current revenue multiple of Cofoe Medical is 2.9x. |
| Is Cofoe Medical profitable? | Yes, Cofoe Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cofoe Medical? | Cofoe Medical's last 12 months EBITDA is $89M. |
| What is Cofoe Medical's EBITDA margin? | Cofoe Medical's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Cofoe Medical? | Current EBITDA multiple of Cofoe Medical is 17.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.